These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 33745199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
    Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, Mahjoub T, Almawi WY.
    Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
    [Abstract] [Full Text] [Related]

  • 3. Association of the polymorphisms in FOXO1 gene and diabetic nephropathy risk.
    Ma J, Pei Y, Xue P, Wang Y, Bao X, Li Y.
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1471-1475. PubMed ID: 30987438
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic Association of Interleukin 16 Gene Polymorphisms (rs11556218 & rs4778889) with Type 1 Diabetes in Egyptian Children: A Case-Control Study.
    Ali YBM, Saed MM, Abdel-Hakem NE, Hussein MAEA, El-Shahat M.
    Immunol Invest; 2024 Jul; 53(5):830-842. PubMed ID: 38771670
    [Abstract] [Full Text] [Related]

  • 8. IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from western Mexico.
    Chavarria-Buenrostro LE, Hernandez-Bello J, Muñoz-Valle JF, Macias-Barragan J, Hernandez-Carrillo LB, Topete-Reyes JF, Parra-Michel R, Ramirez-Dueñas MG, Sanchez-Hernandez PE, Pereira-Suarez AL, Oceguera-Contreras E, Montoya-Buelna M.
    J Clin Lab Anal; 2019 Feb; 33(2):e22691. PubMed ID: 30345559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
    Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY.
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
    [Abstract] [Full Text] [Related]

  • 11. Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio.
    Ururahy MA, de Souza KS, Oliveira YM, Loureiro MB, da Silva HP, Freire-Neto FP, Bezerra JF, Luchessi AD, Doi SQ, Hirata RD, Almeida Md, Arrais RF, Hirata MH, de Rezende AA.
    Diabetes Metab Res Rev; 2015 Jul; 31(5):500-6. PubMed ID: 25384728
    [Abstract] [Full Text] [Related]

  • 12. Association between CNR1 gene polymorphisms and susceptibility to diabetic nephropathy in Iraqi patients with T2DM.
    Aljorani RH, Saleh ES, Al Mohammadawi KG.
    J Med Life; 2023 Nov; 16(11):1663-1669. PubMed ID: 38406790
    [Abstract] [Full Text] [Related]

  • 13. Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.
    Yin Q, Zhai Q, Wang D, Hai J, Cao M, Wang J, Wang T.
    Int J Clin Exp Pathol; 2015 Nov; 8(11):15216-21. PubMed ID: 26823869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.
    Hameed I, Masoodi SR, Malik PA, Mir SA, Ghazanfar K, Ganai BA.
    Gene; 2018 Jun 30; 661():51-59. PubMed ID: 29605608
    [Abstract] [Full Text] [Related]

  • 16. SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study.
    Gu HF, Alvarsson A, Efendic S, Brismar K.
    Gend Med; 2009 Dec 30; 6(4):555-64. PubMed ID: 20114006
    [Abstract] [Full Text] [Related]

  • 17. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D, Ma J, Brismar K, Efendic S, Gu HF.
    J Diabetes Complications; 2009 Dec 30; 23(4):265-72. PubMed ID: 18599322
    [Abstract] [Full Text] [Related]

  • 18. Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.
    El-Sherbini SM, Shahen SM, Mosaad YM, Abdelgawad MS, Talaat RM.
    Acta Biochim Biophys Sin (Shanghai); 2013 Apr 30; 45(4):330-8. PubMed ID: 23399816
    [Abstract] [Full Text] [Related]

  • 19. Genetic evaluation of the TNF-α -238G>A and -308G>A promoter polymorphisms in Croatian patients with type I diabetes.
    Korolija M, Hadžija M, Medvidović EP, Pavkovic P, Kapitanović S, Renar IP, Hadžija MP.
    Hum Immunol; 2010 Dec 30; 71(12):1228-32. PubMed ID: 20849900
    [Abstract] [Full Text] [Related]

  • 20. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY.
    Diabetes Metab Res Rev; 2009 Nov 30; 25(8):717-24. PubMed ID: 19787680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.